DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Sensipar (Cinacalcet Hydrochloride) - Drug Interactions, Contraindications, Overdosage, etc



Drug Interactions and/or Drug/Laboratory Test Interactions

See CLINICAL PHARMACOLOGY, Pharmacokinetics and Drug Interactions


Doses titrated up to 300 mg once daily have been safely administered to patients on dialysis. Overdosage of Sensipar® may lead to hypocalcemia. In the event of overdosage, patients should be monitored for signs and symptoms of hypocalcemia and appropriate measures taken to correct serum calcium levels (see PRECAUTIONS).  

Since Sensipar® is highly protein bound, hemodialysis is not an effective treatment for overdosage of Sensipar®.


Sensipar® is contraindicated in patients with hypersensitivity to any component(s) of this product.


1. National Kidney Foundation: K/DOQI clinical practice guidelines: bone metabolism and disease in chronic kidney disease. American Journal of Kidney Disease 4 2:S1-S201, 2003

Manufactured for: Amgen
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799

©2004-2010 Amgen Inc. All rights reserved.

This Product was Repackaged By:

State of Florida DOH Central Pharmacy
104-2 Hamilton Park Drive
Tallahassee, FL 32304
United States

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017